• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Millipore Corp.

Medtech personnel moves for the week of Mar. 10, 2014

March 11, 2014 By MassDevice staff Leave a Comment

ConMed proxy war gets ugly

February 28, 2014 by Brad Perriello

ConMed proxy war gets ugly

The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.

Filed Under: News Well Tagged With: Alere, becton dickinson, Boston Scientific, Carlyle Group, ConMed Corp., Coppersmith Capital Management, Cutera Inc., Delcath Systems Inc., Johnson and Johnson, Kaiser Permanente Ventures, Masimo, Merck KGaA, Millipore Corp., National Quality Forum, Ortho-Clinical Diagnostics, Personnel Moves, Premier Inc., Roche, Stryker, Varian Medical Systems, Vexim, Voce Capital Management

Madaus is new CEO at Carlyle’s Ortho-Clinical Diagnostics

February 27, 2014 By Chris Walker Leave a Comment

Dr. Madaus is new CEO of Ortho-Clinical Diagnostics

The Carlyle Group said it tapped Martin Madaus to take over as CEO of the Ortho-Clinical Diagnostics business it’s acquiring from Johnson & Johnson (NYSE:JNJ).

Filed Under: Diagnostics, News Well Tagged With: Carlyle Group, Johnson and Johnson, Merck KGaA, Millipore Corp., Ortho-Clinical Diagnostics, Personnel Moves, Roche

Merck closes Millipore acquisition

July 15, 2010 By MassDevice staff Leave a Comment

MRK, MIL logo

Merck KGaA (NYSE:MRK) closed its deal to acquire Millipore Corp. (NYSE:MIL) for $6 billion in cash plus about $890 million in Millipore debt.

The German pharmaceutical and chemical company agreed to pay $107 per share for Billerica, Mass.-based Millipore, which makes which produces specialty filters for water used in laboratory, drug and biotech applications, among other products.

Filed Under: Business/Financial News, Lab Instruments & Supplies, Mergers & Acquisitions, News Well Tagged With: Merck KGaA, Millipore Corp.

Shareholders OK $7.2 billion Merck takeover of Millipore

June 3, 2010 By MassDevice staff Leave a Comment

MIL logo

Millipore Corp. (NYSE:MIL) shareholders approved a $7.2 billion merger proposed by German pharmaceutical giant Merck KGaA (NYSE:MRK).

The $107-per-share deal, announced in February, would see Merck take on another $890 million in Millipore debt.

Filed Under: Business/Financial News, Mergers & Acquisitions, News Well Tagged With: Merck KGaA, Millipore Corp.

Gabelli maneuvers for last-minute profits from Millipore

April 16, 2010 By Dave Price Leave a Comment

MIL logo

No matter how slim the margin, Mario Gabelli isn’t someone to let a potential profit slip away.

Gabelli, the chief investment officer, CEO and founder of Gamco Investors Inc. (NYSE:GBL) and a longtime advocate of value investing, recently put up over $200 million to squeeze out the last bit of profit possible from owning Millipore Corp. (NYSE:MIL) stock.

Filed Under: Business/Financial News, Diagnostics, Lab Instruments & Supplies, News Well Tagged With: Gamco Investors Inc., Millipore Corp.

Thermo Fisher likely upped Millipore bid three times

March 31, 2010 By MassDevice staff Leave a Comment

MIL logo

The CEO of a laboratory science company — most likely Thermo Fisher Scientific Inc.’s (NYSE:TMO) Marc Casper — helped set off the bidding contest for Millipore Corp. (NYSE:MIL) when he proposed a cash acquisition of the maker of filters and instruments in a Jan. 4 letter to company officials, according to recent securities documents.

Filed Under: Business/Financial News, Lab Instruments & Supplies, News Well Tagged With: Merck KGaA, Millipore Corp., Thermo Fisher Scientific

Merck to buy Millipore for $6 billion plus debt

March 1, 2010 By MassDevice staff Leave a Comment

German pharmaceutical and chemical company Merck KGaA (NYSE:MRK) trumped other would-be suitors and struck a deal to acquire Millipore Corp. (NYSE:MIL) for $6 billion in cash plus about $890 million in Millipore debt.

The acquisition was announced early Sunday night by the two companies. At $107 a share, the deal marks just over a 50 percent premium from Millipore’s stock price a week ago, when word leaked that Thermo Fisher Scientific Inc. (NYSE:TMO) was preparing a bid for Millipore.

Filed Under: Biotech, Business/Financial News, News Well Tagged With: Merck KGaA, Millipore Corp.

Thermo Fisher may boost Millipore bid

February 26, 2010 By MassDevice staff Leave a Comment

Thermo Fisher Scientific Inc. (NYSE:TMO) may soon boost its initial $6 billion offer in order to reel in Millipore Corp. (NYSE:MIL).

Bloomberg News, citing a person close to the situation, said Waltham, Mass.-based Thermo Fisher was considering offering a higher price for Millipore. The source did not provide Bloomberg with a specific price, although the news service reported that any deal would include Thermo Fisher taking on Millipore’s $890 million in long-term debt.

Filed Under: Business/Financial News, Diagnostics, News Well Tagged With: Millipore Corp., Thermo Fisher Scientific

Millipore confirms it’s considering buyout bid, “strategic alternatives”

February 24, 2010 By MassDevice staff Leave a Comment

The “For Sale” sign officially went up outside Millipore Corp. (NYSE:MIL).

Responding to speculation that it’s the target of a $6 billion buyout offer, executives at the Billerica, Mass.-based maker of bioscience equipment late Feb. 23 confirmed they hired Goldman Sachs to assist them in “evaluating strategic alternatives, including pursuing a process with potential bidders to explore a possible merger or sale of the company.”

Filed Under: Business/Financial News, Lab Instruments & Supplies, Mergers & Acquisitions, News Well Tagged With: Millipore Corp., Thermo Fisher Scientific

Millipore jumps on reports of $6 billion Thermo Fisher buyout

February 22, 2010 By MassDevice staff Leave a Comment

Millipore Corp. (NYSE:MIL) shares soared as much as 43 percent today after news reports that Thermo Fisher Scientific (NYSE:TMO) is considering a $6 billion unsolicited bid for the Billerica, Mass.-based company.

Bloomberg News, citing a person familiar with the situation, said Millipore recently hired Goldman Sachs as its financial adviser after receiving the bid and that a deal could be agreed on as early as next week. The news service said the person did not want to be identified because the talks are not yet public.

Filed Under: Business/Financial News, Lab Instruments & Supplies, Mergers & Acquisitions, News Well Tagged With: Millipore Corp., Thermo Fisher Scientific

FDA issues warnings, recall

February 3, 2010 By MassDevice staff Leave a Comment

The Food & Drug Administration issues a pair of warnings to Millipore Corp. (NYSE:MIL) and Cardiac Sciences Corp. (NSDQ:CSCX) and put out a Class I recall of Synthes USA’s (SIX:SYST) Synex II vertebral implant.

Millipore warned on Swine Flu diagnostics claims

The FDA sent the Billerica, Mass.-based lab instruments maker a warning letter in September of last year about a promotional email the company sent out touting its influenza diagnostics.

Filed Under: Business/Financial News, Diagnostics, News Well, Spine Tagged With: Cardiac Sciences Corp., depuysynthes, Millipore Corp., Swine Flu

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS